Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
CureVac N.V. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $180.54M | $149.73M - $200.86M | -$130.29M | -$0.549 | 2 |
| Dec 2028 | $173.56M | $143.94M - $193.09M | -$125.25M | -$0.638 | 1 |
| Dec 2027 | $136.03M | $112.81M - $151.34M | -$98.16M | -$0.085 | 1 |
| Dec 2026 | $84.91M | $70.42M - $94.46M | -$61.27M | -$0.418 | 3 |
| Dec 2025 | $58.67M | $48.66M - $65.27M | -$42.34M | -$0.485 | 2 |
| Dec 2024 | $516.78M | $509.06M - $524.50M | -$372.93M | $0.793 | 4 |
| Dec 2023 | $55.27M | $54.60M - $55.94M | -$39.89M | -$0.974 | 10 |
| Dec 2022 | $60.96M | $44.99M - $74.12M | -$43.99M | -$0.918 | 1 |
| Dec 2021 | $66.32M | $48.95M - $80.64M | -$47.86M | -$3.228 | 2 |
| Dec 2020 | $71.41M | $52.70M - $86.83M | -$51.53M | -$2.357 | 2 |